In colon cancer, the expressions of SUCLG2 and SUCLG2P2 are reduced, the competitive binding hsa-miR-588 is reduced, hsa-miR-588 is increased, and hsa-miR-588 exerts a tumor suppressor effect. The gene discussed is SUCLG2P2; the disease is malignant colon neoplasm.